The rising median age of people around the world has the same effect, since cancer can take decades to develop and therefore ...

In a new study published in Cancer Immunology Research, scientists at the Icahn School of Medicine at Mount Sinai have developed a novel method to generate billions of rare immune cells known as ...

In a wholly new approach to cancer treatment, Northwestern University biomedical engineers have doubled the effectiveness of ...

In a new study, researchers have uncovered how exercise might help the immune system fight cancer: by changing the gut ...

A U.S. scientist in Oviedo, Spain, is advancing cancer research with a focus on epigenetics and immunity. Her project ...

New RNA vaccine shows promise in turning resistant tumors into immunotherapy targets. Study offers hope for more effective, ...

Two junior research groups at Ruhr University Bochum, Germany, have developed a drug complex that kills cancer cells in such a clever manner that they raise a red flag as they die. They signal to the ...

Bristol Myers Squibb said on Friday its blockbuster drug Reblozyl in combination with another therapy failed to meet the main ...

Esophageal squamous cell carcinoma (ESCC) is a deadly cancer with particularly high prevalence in East Asia. While ...

Replimune faces FDA hurdles for RP1, an innovative melanoma treatment, as it seeks a path forward after receiving a complete ...

“Cancer cells are great adapters,” said Northwestern Engineering’s Vadim Backman, who led the study. “They can adapt to almost anything that’s thrown at them. First, they learn to evade the immune ...

I N 1971 RICHARD NIXON, then America’s president, announced a “war on cancer”. Just two years earlier the Apollo programme ...